Carvana Is Up 27% in April: What's Driving the Rally?

Carvana is trading around $400, up 27% since the start of April, ahead of Q1 2026 results on April 29. The stock is being supported by a Q4 2025 earnings beat ($4.22 EPS vs. $1.09 consensus), 58% revenue growth to $5.60 billion, a Stephens price-target raise to $519, and S&P 500 inclusion, but BofA remains cautious with a $360 target and Neutral rating. Management has guided for sequential growth in retail units and Adjusted EBITDA, and the market will likely focus on whether the rally can be sustained versus short-covering and stretched valuation.

Analysis

CVNA’s tape is being supported by a rare combination of reflexive forces: improving fundamentals, forced ownership from index inclusion, and a still-lean short base. That mix matters because when a stock is already crowded on the short side, each incremental positive datapoint can trigger a disproportionate move as hedges are covered and momentum funds add exposure; the first derivatives of the business matter less than the market’s positioning state into the print.

The key second-order issue is that operational improvement may already be discounted relative to what management needs to say next. At this valuation, the market is implicitly paying for another step-up in unit growth and margin durability, not just “good” earnings; if guidance merely confirms the current trajectory, the stock can still sell off on de-risking. In other words, the hurdle is not whether the business is better, but whether the next six months are better than the street’s now-ratcheted expectations.

BAC’s downgrade is more important as a sentiment tell than as a fundamental thesis. When a name is this controversial and heavily shorted, bearish analyst calls often lag the actual inflection and become fuel for squeezes; but they also highlight the core fragility here: rate sensitivity and credit friction can hit used-car demand with a lag even if near-term unit data looks fine. That makes this an event-driven trade, not a clean secular compounder at current multiples.

The base case is asymmetric around the earnings call: upside is capped by already-extended positioning, while downside can be swift if management avoids re-affirming the long-term margin path or if incremental growth is less linear. The real contrarian risk is not a bad quarter; it is a merely adequate quarter paired with soft forward commentary, which would force quant and momentum holders to de-risk simultaneously. If they hit the long-term unit and EBITDA milestones cleanly, the squeeze can extend; if not, the stock has little valuation support below.

Key Decisions for Investors

• Do not chase CVNA outright ahead of earnings; wait for the print and sell-side Q&A to confirm whether guidance supports the current multiple. Risk/reward is better after the event because implied expectations are already elevated.
• For accounts needing exposure, use a call spread rather than stock: buy CVNA Jun-2026 upside calls and finance part of it by selling a higher strike. This captures squeeze potential while defining risk if the reaction is merely in-line.
• Consider a short-dated earnings straddle only if options pricing has not fully embedded the event risk; the setup favors a large move in either direction, but the skew is toward a gap if guidance disappoints. Keep size small because IV will likely be expensive.
• Pair idea: long a lower-multiple used-auto or auto-services beneficiary vs short CVNA into the event. The thesis is that better fundamentals elsewhere can monetize the same consumer down-trade without paying 50x+ earnings for the narrative.
• If CVNA gaps higher on confirmation, trim into strength rather than add. The first post-earnings move can be dominated by covering and index flows, but follow-through beyond the initial squeeze will require evidence that growth and margin expansion are still accelerating into Q2.